BLACK DIAMOND THERAPEUTICS, INC. financial statements (2021 and earlier)

Company profile

Business Address ONE MAIN STREET, 10TH FLOOR
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments315155
Cash and cash equivalents35155
Short-term investments280 
Restricted cash and investments10
Other undisclosed current assets31
Total current assets:320156
Noncurrent Assets
Operating lease, right-of-use asset8 
Property, plant and equipment00
Restricted cash and investments10
Deferred costs 2
Other noncurrent assets00
Total noncurrent assets:103
TOTAL ASSETS:330158
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities145
Accounts payable32
Accrued liabilities123
Total current liabilities:145
Noncurrent Liabilities
Long-term debt and lease obligation8 
Operating lease, liability8 
Liabilities, other than long-term debt 0
Derivative instruments and hedges, liabilities 0
Other undisclosed noncurrent liabilities(8) 
Total noncurrent liabilities:80
Total liabilities:225
Temporary equity, carrying amount 201
Stockholders' equity
Stockholders' equity attributable to parent308(47)
Common stock00
Additional paid in capital4254
Accumulated other comprehensive income1 
Accumulated deficit(118)(51)
Total stockholders' equity:308(47)
TOTAL LIABILITIES AND EQUITY:330158

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
Gross profit:0 
Operating expenses(70)(29)
Other undisclosed operating loss(0) 
Operating loss:(70)(29)
Nonoperating income (expense)2(6)
Investment income, nonoperating40
Other nonoperating income (expense)(2)0
Interest and debt expense(0) 
Net loss:(67)(35)
Other undisclosed net income attributable to parent0 
Net loss available to common stockholders, diluted:(67)(35)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
Net loss:(67)(35)
Comprehensive loss:(67)(35)
Other undisclosed comprehensive income, net of tax, attributable to parent1 
Comprehensive loss, net of tax, attributable to parent:(67)(35)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: